Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does rs41272114 CC indicate absence of the low-production T allele?

The CC genotype at rs41272114 indicates the individual does not carry the T loss-of-function allele that lowers Lp(a) production.

PlausibleJune 19, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The LPA rs41272114 T allele is a loss-of-function variant associated with lower lipoprotein(a) levels, so rs41272114 CC is consistent with absence of this low-production allele.

laying out figure…
3 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that the rs41272114 T allele is a splice-site loss-of-function variant that reduces apo(a) synthesis and therefore lowers circulating Lp(a). The CC genotype, by definition, lacks the T allele and is consistent with the reference (standard-production) state at this locus, meaning this specific genetic brake on Lp(a) is absent.

Verified conclusion

The LPA gene, which encodes apolipoprotein(a), is the primary genetic determinant of circulating lipoprotein(a) [Lp(a)] levels. The rs41272114 variant is a key single nucleotide polymorphism (SNP) used to refine genetic predictions of an individual's Lp(a) profile.

Clinical and genetic findings

Evidence confirms that the rs41272114 SNP is a primary causal driver of plasma Lp(a) concentrations.

  • Genotype interpretation: The CC genotype represents the wild-type or reference state. The presence of the T allele (often referred to as the minor A allele in some nomenclature) is strongly associated with significantly reduced Lp(a) levels.
  • Association with Lp(a) levels: In large cohort studies, such as the Cooperative Health Research in the Region of Augsburg (KORA) F4 study, rs41272114 has been identified as a major determinant of Lp(a) variance. It is frequently included in high-accuracy predictive models alongside kringle IV type-2 (KIV-2) copy numbers to estimate serum concentrations.
  • Absence of the variant: An individual with the rs41272114 CC genotype does not carry the low-production T allele. Consequently, this genotype is consistent with the "high-production" reference state at this specific locus, meaning this particular genetic brake on Lp(a) production is absent.

Mechanistic explanations

The rs41272114 T allele functions as a loss-of-function variant through the disruption of normal protein synthesis.

  • Splice-site disruption: The T allele (c.4925G>A) acts as a splice-site variant. This mutation interferes with the standard mRNA splicing process, which is a critical step in the production of functional apolipoprotein(a).
  • Impact on apo(a) secretion: By disrupting splicing, the T allele leads to a substantial decrease in the production and subsequent secretion of apo(a) into the plasma. This mechanism places rs41272114 in a category of variants—alongside nonsense mutations (e.g., R21X) and other splice-site mutations—that effectively lower Lp(a) levels regardless of the individual's KIV-2 copy number.

Bottom line

The rs41272114 T allele is a validated loss-of-function splice-site variant that significantly lowers Lp(a) production. Therefore, a CC genotype confirms the absence of this specific low-production allele, representing the standard-production genetic state at this locus.

References

  1. Comprehensive analysis of the genetic variation in the LPA gene from short-read sequencing — mdpi.com ↗
  2. Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population — dx.plos.org ↗
  3. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes. — linkinghub.elsevier.com ↗
  4. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. — pmc.ncbi.nlm.nih.gov ↗
  5. The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat — linkinghub.elsevier.com ↗
  6. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene — pmc.ncbi.nlm.nih.gov ↗
  7. Prevalence and influence of LPA gene variants and isoform size on the Lp(a)-lowering effect of pelacarsen. — linkinghub.elsevier.com ↗
  8. Comprehensive analysis of the genetic variation in the LPA gene from short-read sequencing — medrxiv.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→